Insider Trading June 15, 2026 02:52 PM

Kaltura Executive Eynav Azaria Executes $9,811 Stock Sale Under Pre-Arranged Plan

Kaltura (NASDAQ: KLTR) officer liquidates shares while the company navigates post-earnings market reaction and valuation assessments.

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
KLTR

Eynav Azaria, an officer at Kaltura Inc. (NASDAQ: KLTR), completed a sale of 6,975 shares of common stock on June 9, 2026, totaling $9,811. The transaction, executed between $1.40 and $1.43 per share, was conducted under a Rule 10b5-1 trading plan established in December 2025. This sale reduces Azaria's direct holding to 2,241,079 shares. The transaction occurs against a backdrop of mixed market signals for Kaltura, which recently reported a revenue beat for Q1 2026 but saw its stock decline in aftermarket trading. Current valuation metrics suggest the stock may be overvalued relative to fair value, while the broader market context reflects cautious investor sentiment amid strategic investments and economic navigation.

Kaltura Executive Eynav Azaria Executes $9,811 Stock Sale Under Pre-Arranged Plan
KLTR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Eynav Azaria sold 6,975 shares of Kaltura stock for $9,811 under a Rule 10b5-1 plan adopted in December 2025.
  • Kaltura reported Q1 2026 revenue of $44.6 million, beating analyst estimates of $44.39 million, while EPS matched forecasts at $0.01.
  • The stock trades at $1.47, down 15% year-to-date, with analysis suggesting it is overvalued relative to Fair Value.

Eynav Azaria, an officer at Kaltura Inc. (NASDAQ: KLTR), has executed a sale of 6,975 shares of the company's common stock. The transaction, finalized on June 9, 2026, resulted in a total value of $9,811. The shares were liquidated at prices ranging from $1.40 to $1.43 per share, with the reported weighted average price of $1.4066 reflecting the multiple transactions involved in the sale.

This transaction was carried out pursuant to a Rule 10b5-1 trading plan that Azaria adopted on December 15, 2025. Following the completion of this sale, Azaria's direct holding in Kaltura common stock stands at 2,241,079 shares. The execution of this sale occurs while Kaltura's stock is trading at $1.47, a figure that marks a decline of approximately 15% year-to-date and 30% over the past year.

Market analysis indicates that the stock appears overvalued relative to its Fair Value. This valuation context is particularly relevant as Kaltura recently announced its Q1 2026 earnings, revealing financial performance that exceeded analyst expectations. The company reported revenue of $44.6 million, surpassing the consensus forecast of $44.39 million. Earnings per share (EPS) matched projections at $0.01.

Despite the revenue beat, Kaltura's stock experienced a decline in aftermarket trading. The market's response appears cautious, reflecting mixed signals from the company's financial performance and strategic investments. These developments are part of Kaltura's ongoing efforts to navigate the current economic landscape. Investors seeking deeper insights into these metrics may find value in comprehensive Pro Research Reports covering over 1,400 US equities, which transform complex data into actionable intelligence.

The intersection of insider activity, valuation metrics, and post-earnings market reaction highlights the complex dynamics at play for Kaltura. While the company demonstrates revenue growth, the market's cautious response and the insider's adherence to a pre-arranged trading plan suggest a nuanced environment for stakeholders.

Risks

  • Kaltura's stock price has declined 30% over the past year and 15% year-to-date, indicating significant downward pressure.
  • The market's cautious response to a revenue beat suggests mixed signals regarding the company's strategic investments and financial health.
  • Valuation analysis indicates the stock may be overvalued relative to its Fair Value, posing potential risks for investors.

More from Insider Trading

Block Director Executes Pre-Arranged Sale as Analysts Adjust Pricing Models Ahead of Q2 Earnings Jul 30, 2026 Viking Therapeutics Executive Liquidates Shares to Cover Vesting Tax Obligations Jul 29, 2026 TransUnion Executive Sells Equity as Q2 Earnings Beat Consensus Estimates Jul 29, 2026 Tenet Healthcare Director James Bierman Offloads $1.22 Million in Shares Amid Strong Earnings Backdrop Jul 28, 2026 Portland General Electric Director Executes Strategic Share Transactions Amid Earnings Recalibration Jul 28, 2026